93.71 0.00 (0.00%)
After hours: 5:00PM EDT
|Bid||94.03 x 800|
|Ask||94.08 x 1100|
|Day's Range||93.65 - 97.04|
|52 Week Range||70.83 - 98.33|
|Beta (3Y Monthly)||1.41|
|PE Ratio (TTM)||43.91|
|Earnings Date||Apr 29, 2019 - May 3, 2019|
|Forward Dividend & Yield||0.28 (0.29%)|
|1y Target Est||95.69|
PerkinElmer Inc NYSE:PKIView full report here! Summary * Perception of the company's creditworthiness is neutral * Bearish sentiment is low and declining Bearish sentimentShort interest | PositiveShort interest is low for PKI with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 4. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold PKI had net inflows of $5.35 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. PKI credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why itRead More...
PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019, at 1:30 p.m. ET at the Marriott Copley Place in Boston. Prahlad Singh, PerkinElmer’s president and chief operating officer, will provide an overview of the Company and its strategic priorities.
Baltimore-based T. Rowe Price's funds, and the stock market overall, were hit hard by the stock market's dramatic plunge in December.
NEW YORK , Feb. 11, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...
NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! PerkinElmer, Inc.'s (NYSE:PKI) most recent earnings update Read More...
WALTHAM, Mass.-- -- Fourth Quarter 2018 GAAP revenue growth of 18% to $756.3 million; Core organic revenue growth of 7% Fourth Quarter 2018 GAAP earnings per share from continuing operations of $0.64; Adjusted earnings per share of $1.18 Receives CE-IVD Mark for Vanadis NIPT Initiates FY19 GAAP earnings per share guidance range of $2.93 to $2.98 from continuing operations; Adjusted EPS guidance of ...
Cerner's (CERN) fourth-quarter 2018 results are likely to be hurt by year-over-year decline in bookings; Q4 guidance promising.
AmerisourceBergen's (ABC) first-quarter fiscal 2019 results are likely to gain from its core Pharmaceutical Distribution business unit.
Edwards Lifesciences (EW) expected to see consistent performance by Surgical Structural Heart and Critical Care segments in Q4.
The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on January 24, 2019. This dividend is payable on May 10, 2019 to all shareholders of record at the close of business on April 19, 2019.
PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength in the Breast Health business, Panther system and international business is likely to boost Hologic's (HOLX) top line in Q1.
Align Technology (ALGN) is likely to gain from strength in Invisalign space as well as Scanner and Service business in fourth-quarter 2018.